CTMX: Cytomx Therapeutics Inc

FinancialsDividends

$2.00

-0.12

(-5.66%)

As of 08/19/2025 5:00 PM ET • Disclaimer
Powered by Stocksift.com

100%

CTMX Performance Snapshot

1-Week Chg

7.53%

1-Month Chg

-16.14%

3-Month Chg

-6.10%

6-Month Chg

149.69%

1-Year Chg

62.60%

Year-To-Date Chg

88.68%

Beta 1-Year

3.46

Beta 5-Year

1.84

Volatility (10-Day)

9.77%

CTMX Technical Snapshot

Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-08-19

$2

-$0.12 (-5.66%)

$2.13

$2.15

$1.98

$2.04

3.00M ($6.00M)

2025-08-18

$2.12

$0.21 (10.99%)

$1.95

$2.15

$1.90

$2.06

7.63M ($16.19M)

2025-08-15

$1.91

$0.15 (8.52%)

$1.78

$1.96

$1.77

$1.88

9.89M ($18.89M)

2025-08-14

$1.76

-$0.01 (-0.85%)

$1.80

$1.81

$1.72

$1.76

6.54M ($11.51M)

2025-08-13

$1.77

-$0.09 (-4.57%)

$1.90

$2.08

$1.77

$1.88

10.54M ($18.71M)

2025-08-12

$1.86

-$0.45 (-19.48%)

$2.24

$2.27

$1.83

$1.99

11.21M ($20.84M)

2025-08-11

$2.31

-$0.04 (-1.7%)

$2.32

$2.43

$2.29

$2.34

1.20M ($2.77M)

2025-08-08

$2.35

$0.25 (11.9%)

$2.05

$2.40

$2.03

$2.26

2.20M ($5.16M)

2025-08-07

$2.10

-$0.07 (-3.23%)

$2.20

$2.23

$2.07

$2.13

2.73M ($5.74M)

2025-08-06

$2.17

-$0.20 (-8.44%)

$2.39

$2.39

$2.15

$2.24

1.93M ($4.18M)

CTMX Financial Snapshot

Balance Sheet

(USD)

2025 Q2

Y/Y CHANGE

  • Cash and equivalents

    $50.07M

    13.37%

  • Total assets

    $175.06M

    9.95%

  • Total liabilities

    $55.15M

    -71.04%

  • Total investments

    $109.05M

    16.09%

  • Shareholders' equity

    $119.91M

    483.99%

  • Book value per share

    $0.93

    352.45%

Income Statement

(USD)

2025 Q2

Y/Y CHANGE

  • Revenue

    $18.66M

    -25.71%

  • Net income

    -$154.00K

    97.64%

  • Operating expense

    $19.94M

    -40.58%

  • Gross profit

    $18.66M

    -25.71%

  • EBITDA

    $1.36M

    127.20%

  • Earnings per share

    $0

    100.00%

Cash Flow

(USD)

2025 Q2

Y/Y CHANGE

  • Net change in cash

    $1.44M

    -79.65%

  • Cash from operations

    -$15.75M

    19.42%

  • Cash from investing

    -$76.36M

    -454.96%

  • Cash from financing

    $93.55M

    1734.67%

  • Free cash flow

    -$15.78M

    19.67%

  • Free cash flow per share

    -$0.12

    47.19%

Metrics

(USD)

2025 Q2

Y/Y CHANGE

  • Market capitalization

    $183.01M

    92.52%

  • Enterprise value

    $142.53M

    101.22%

  • Shares outstanding

    80.62M

    3.47%

  • Profit margin

    -0.80%

    96.92%

  • Gross margin

    100.00%

    0%

  • EBITDA margin

    7.30%

    136.50%

Dividends

(USD)

2025 Q2

Y/Y CHANGE

  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    -

    -

  • Coverage ratio

    -

    -

  • Current ratio

    4.20

    318.86%

View Financial Statements